Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 12,514 | 5,285 | 22,939 | 7,923 | 316,815 |
| Gross Profit | 12,514 | 5,285 | 22,939 | 7,923 | 316,815 |
| Operating Expenses | 89,635 | 90,878 | 84,756 | 79,143 | 72,737 |
| Operating Income | -77,121 | -85,593 | -61,817 | -71,220 | 244,078 |
| Other Income | 1,285 | 1,005 | 1,126 | 1,179 | 1,630 |
| Pre-tax Income | -75,836 | -84,588 | -60,691 | -70,041 | 245,708 |
| Income Tax | N/A | N/A | N/A | N/A | 823 |
| Net Income Continuous | -75,261 | -84,588 | -60,691 | -70,041 | 244,885 |
| Net Income | $-75,261 | $-84,588 | $-60,691 | $-70,041 | $244,885 |
| EPS Basic Total Ops | -0.62 | -0.69 | -0.50 | -0.58 | 2.30 |
| EPS Basic Continuous Ops | -0.62 | -0.69 | -0.50 | -0.58 | 2.30 |
| EPS Diluted Total Ops | -0.62 | -0.69 | -0.50 | -0.58 | 2.28 |
| EPS Diluted Continuous Ops | -0.62 | -0.69 | -0.50 | -0.58 | 2.28 |
| EBITDA(a) | $-72,595 | $-80,746 | $-57,118 | $-67,951 | $247,328 |